Press releases

Advanced Search
  • Jul 19, 2017
    BD FACSLyric(TM) Flow Cytometer System with BD Multitest(TM) Assays Offers Reliability and Consistency

    BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA)...

  • Jul 18, 2017
    New BD Kiestra(TM) Urine Culture App1 Drives Increased Lab Efficiency and Impacts Patient Management

    BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced new technology that can automatically report and release negative urine cultures. Every...

  • Jun 20, 2017
    New Micro-Laparoscopic Instruments Offer Surgeons Less Invasive Option for Patients

    BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that its new line of Snowden-Pencer((TM)) 3.0mm laparoscopic ergonomic take-apart...

  • Jun 13, 2017
    Leaders in flow cytometry tools collaborate to deliver cloud data management capabilities and streamline experimental execution

    ASHLAND, Ore and FRANKLIN LAKES, N.J., June 13, 2017 ─ FlowJo, LLC, a life science informatics and data analysis company with 20 years of experience in software for analyzing single-cell data,...

  • Jun 6, 2017

    FRANKLIN LAKES, N.J., June 6, 2017 – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued its 2016 Sustainability Report. BD’s...